Diffuse large B-cell lymphoma (DLBCL) is the most common type of adult lymphoma and accounts for 40-50% of non-Hodgkin's lymphomas. Approximately half of the patients can be cured by chemotherapy. As a prognostic factor of non-Hodgkin's lymphoma, the International Prognostic Index (IPI) is generally used (1
et al (3) identified two types of DLBCL which have different states of differentiation based on the gene expression of corresponding normal B-cells, and reported that patients with germinal center B-like (GCB) DLBCL, which showed the gene expression profiles of germinal center Bcells, had a significantly better prognosis than those with activated B-like (ABC) DLBCL, which showed gene expression profiles similar to mitogen-activated peripheral B-cells in vitro. Later, they evaluated the state of the somatic mutations in the immunoglobulin heavy chain genes in these pa

